Distribution and radioimmunoimaging of 131I labeled anti-NPC monoclonal antibody BAC5 in tumor bearing nude mice

To provide an evidence for clinical applications, the distribution and radioimmunoimaging of 131I labeled anti nasopharyngeal carcinoma (NPC) monoclonal antibody BAC5 in tumor bearing nude mice were studied. McAb BAC5, against NPC, was labeled with 131I and injected into nude mice bearing NPC cell line CNE-2. The biodistribution of 131I-BAC5 and whole body ECT imaging were studied at various intervals after injection. The % ID/g were 6.38, 11.27 and 14.19 for tumor and 7.78, 3.48 and 2.59 for liver at 48, 96 and 144h postinjection respectively. The T/NT ratios were 0.82, 3.24 and 5.47 for liver at 48, 96 and 144h postinjection respectively. Tumor showed clearly at 3 days after injection. The quality of tumor images was relevant to the T/NT ratio. The results demonstrated that McAb BAC5 has specifically bind to NPC tissue and may also possess the capability of leading to human NPC